ScholarLens Back to search
2014•中国医学文摘：内科学分册（英文版）Requires access

Application of arginase-1 and glypican-3 combined examination in differential diagnosis of hepatocellular carcinoma

顾春燕

Open publisher page 0 citations

Abstract

Objective To explore the value of arginase-1(Arg-1)and glypican-3(GPC-3)combined examination in the differential diagnosis of hepatocellular carcinoma(HCC),metastatic carcinoma(MC)of liver and intrahepatic cholangiocarcinoma(ICC).Methods From January2005 to December 2011,a total of 54 patients with HCC were selected,including 10 cases with high differentiation,25 cases with moderate differentiation and 19 cases with poor differentiation.At the same time,25 patients with MC of liver and 20 patients with ICC were selected.

About this research paper

What this paper is about

Objective To explore the value of arginase-1(Arg-1)and glypican-3(GPC-3)combined examination in the differential diagnosis of hepatocellular carcinoma(HCC),metastatic carcinoma(MC)of liver and intrahepatic cholangiocarcinoma(ICC).Methods From January2005 to December 2011,a total of 54 patients with HCC were selected,including 10 cases with high differentiation,25 cases with moderate differentiation and 19 cases with poor differentiation.At the same time,25 patients with MC of liver and 20 patients with ICC were selected.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the value of arginase-1(Arg-1)and glypican-3(GPC-3)combined examination in the differential diagnosis of hepatocellular carcinoma(HCC),metastatic carcinoma(MC)of liver and intrahepatic cholangiocarcinoma(ICC).Methods From January2005 to December 2011,a total of 54 patients with HCC were selected,including 10 cases with high differentiation,25 cases with moderate differentiation and 19 cases with poor differentiation.At the same time,25 patients with MC of liver and 20 patients with ICC were selected.

Key concepts: Arginase, Hepatocellular carcinoma, Glypican 3, Differential diagnosis, Medicine, Internal medicine, Gastroenterology, Carcinoma

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Application of arginase-1 and glypican-3 combined examination in differential diagnosis of hepatocellular carcinoma — Research Paper | ScholarLens